Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis.
Cappelli F, Vignini E, Martone R, Perlini S, Mussinelli R, Sabena A, Morini S, Gabriele M, Taborchi G, Bartolini S, Lossi A, Nardi G, Marchionni N, Di Mario C, Olivotto I, Perfetto F. Cappelli F, et al. Among authors: gabriele m. Circ Heart Fail. 2020 Mar;13(3):e006619. doi: 10.1161/CIRCHEARTFAILURE.119.006619. Epub 2020 Mar 13. Circ Heart Fail. 2020. PMID: 32164434 No abstract available.
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype.
Cappelli F, Zampieri M, Fumagalli C, Nardi G, Del Monaco G, Matucci Cerinic M, Allinovi M, Taborchi G, Martone R, Gabriele M, Ungar A, Moggi Pignone A, Marchionni N, Di Mario C, Olivotto I, Perfetto F. Cappelli F, et al. Among authors: gabriele m. J Intern Med. 2021 Jun;289(6):831-839. doi: 10.1111/joim.13200. Epub 2020 Dec 8. J Intern Med. 2021. PMID: 33615623 Free article.
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives.
Zampieri M, Berteotti M, Ferrantini C, Tassetti L, Gabriele M, Tomberli B, Castelli G, Cappelli F, Stefàno P, Marchionni N, Coppini R, Olivotto I. Zampieri M, et al. Among authors: gabriele m. Curr Heart Fail Rep. 2021 Aug;18(4):169-179. doi: 10.1007/s11897-021-00523-0. Epub 2021 Jun 20. Curr Heart Fail Rep. 2021. PMID: 34148184 Review.
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.
Fumagalli C, Zampieri M, Perfetto F, Zocchi C, Maurizi N, Tassetti L, Ungar A, Gabriele M, Nardi G, Del Monaco G, Baldini K, Tomberli A, Tomberli B, Marchionni N, Di Mario C, Olivotto I, Cappelli F. Fumagalli C, et al. Among authors: gabriele m. Mayo Clin Proc. 2021 Aug;96(8):2185-2191. doi: 10.1016/j.mayocp.2021.04.021. Mayo Clin Proc. 2021. PMID: 34353472
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis.
Zampieri M, Argirò A, Allinovi M, Tassetti L, Zocchi C, Gabriele M, Andrei V, Fumagalli C, Di Mario C, Tomberli A, Olivotto I, Perfetto F, Cappelli F. Zampieri M, et al. Among authors: gabriele m. Int J Cardiol. 2022 Mar 15;351:71-77. doi: 10.1016/j.ijcard.2021.12.048. Epub 2022 Jan 4. Int J Cardiol. 2022. PMID: 34990715
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
Argirò A, Zampieri M, Dei LL, Ferrantini C, Marchi A, Tomberli A, Baldini K, Cappelli F, Favilli S, Passantino S, Zocchi C, Tassetti L, Gabriele M, Maurizi N, Marchionni N, Coppini R, Olivotto I. Argirò A, et al. Among authors: gabriele m. Int J Cardiol. 2023 Jan 1;370:271-278. doi: 10.1016/j.ijcard.2022.10.014. Epub 2022 Oct 10. Int J Cardiol. 2023. PMID: 36228766
313 results